MicroRNA-543 acts as an oncogene by targeting PAQR3 in hepatocellular carcinoma

被引:4
|
作者
Yu, Lei [1 ]
Zhou, Luting [2 ]
Cheng, Yu [1 ]
Sun, Lei [3 ]
Fan, Jian [1 ]
Liang, Jinlong [4 ]
Guo, Mujie [5 ]
Liu, Ning [6 ]
Zhu, Liying [1 ]
机构
[1] Harbin Med Univ, Hosp 4, Dept Infect Dis, Harbin 150001, Heilongjiang, Peoples R China
[2] Jinan Mil Command, Gen Hosp, Dept Pathol, Jinan 250000, Shandong, Peoples R China
[3] Harbin Med Univ, Hosp 4, Dept Ophthalmol, Harbin 150001, Heilongjiang, Peoples R China
[4] Heilongjiang Prov Hosp, Dept Gen Surg, Harbin 150000, Heilongjiang, Peoples R China
[5] Jining Med Univ, Affiliated Hosp, Dept CT, Jining 272029, Shandong, Peoples R China
[6] Jining Med Univ, Dept Informat Technol, Jining 272029, Shandong, Peoples R China
来源
AMERICAN JOURNAL OF CANCER RESEARCH | 2014年 / 4卷 / 06期
关键词
miR-543; PAQR3; hepatocellular carcinoma; oncogene; INHIBITS CELL-PROLIFERATION; CANCER; OSTEOSARCOMA; EXPRESSION; INVASION; MIR-124; MARKER;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MicroRNAs (miRNAs) are small, non-coding RNAs that can act as oncogenes or tumor suppressor genes in human cancer. Increasing evidences indicate that deregulation of miRNAs contributes to the hepatocarcinogenesis. In this study, we demonstrated that the levels of miR-543 were dramatically increased in clinical hepatocellular carcinoma (HCC) tissues and cell lines. Moreover, forced expression of miR-543 promoted the proliferative and invasive potential of HepG2. We also identified PAQR3 as a direct target gene for miR-543 using a fluorescent reporter assay and western blot. The levels of PAQR3 were dramatically decreased in clinical hepatocellular carcinoma (HCC) tissues and cell lines. The mRNA levels of PAQR3 were inversely correlated with the miR-543 expression level. Thus, our finding provides a new insight into the mechanism of hepatocarcinogenesis, indicating a therapeutic potential of miR-543 in the treatment of HCC.
引用
收藏
页码:897 / 906
页数:10
相关论文
共 50 条
  • [31] microRNA-802 accelerates hepatocellular carcinoma growth by targeting RUNX3
    Ni, Min
    Zhao, Yi
    Zhang, Wen-Jing
    Jiang, Yu-Jie
    Fu, Hui
    Huang, Fang
    Li, Dong-Jie
    Shen, Fu-Ming
    JOURNAL OF CELLULAR PHYSIOLOGY, 2020, 235 (10) : 7128 - 7135
  • [32] MicroRNA-144 suppresses tumorigenesis of hepatocellular carcinoma by targeting AKT3
    Ma, Ying
    She, Xing-Guo
    Ming, Ying-Zi
    Wan, Qi-Quan
    Ye, Qi-Fa
    MOLECULAR MEDICINE REPORTS, 2015, 11 (02) : 1378 - 1383
  • [33] MicroRNA-575 acts as a novel oncogene via targeting multiple signaling pathways in glioblastoma
    Gray, Ashley
    Cui, Tiantian
    Bell, Erica Hlavin
    McElroy, Joseph
    Sebastian, Ebin
    Li, Fuhai
    Geurts, Marjolein
    Liu, Kevin
    Robe, Pierre
    Haque, S. Jaharul
    Chakravarti, Arnab
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2022, 128
  • [34] PAQR3 overexpression suppresses the aggressive phenotype of esophageal squamous cell carcinoma cells via inhibition of ERK signaling
    Bai, Ge
    Chu, Jianhu
    Eli, Mayinur
    Bao, Yongxing
    Wen, Hao
    BIOMEDICINE & PHARMACOTHERAPY, 2017, 94 : 813 - 819
  • [35] MicroRNA-543 suppresses liver cancer growth and induces apoptosis via the JAK2/STAT3 signaling pathway
    Xiu, Dianhui
    Wang, Dawei
    Wang, Jing
    Ji, Fujian
    Zhang, Wenlei
    ONCOLOGY LETTERS, 2019, 17 (02) : 2451 - 2456
  • [36] MicroRNA-197-3p acts as a prognostic marker and inhibits cell invasion in hepatocellular carcinoma
    Ni, Jun-Sheng
    Zheng, Hao
    Huang, Zhi-Ping
    Hong, Yong-Gang
    Ou, Yang-Liu
    Tao, Yuan-Ping
    Wang, Meng-Chao
    Wang, Zhen-Guang
    Yang, Yuan
    Zhou, Wei-Ping
    ONCOLOGY LETTERS, 2019, 17 (02) : 2317 - 2327
  • [37] MicroRNA-29c-3p acts as a tumor suppressor gene and inhibits tumor progression in hepatocellular carcinoma by targeting TRIM31
    Lv, Tao
    Jiang, Li
    Kong, Lingxiang
    Yang, Jiayin
    ONCOLOGY REPORTS, 2020, 43 (03) : 953 - 964
  • [38] Associations of the BRAF V600E Mutation and PAQR3 Protein Expression with Papillary Thyroid Carcinoma Clinicopathological Features
    Gao, Jian
    Ma, Xiao Peng
    Deng, Fu Sheng
    Jiang, Lin
    Jia, Wei Dong
    Li, Ming
    PATHOLOGY & ONCOLOGY RESEARCH, 2020, 26 (03) : 1833 - 1841
  • [39] Dynactin 2 acts as an oncogene in hepatocellular carcinoma through promoting cell cycle progression
    Li, Wenchao
    Chen, Jiehuan
    Xiong, Zhiyong
    Zhou, Hui
    Huang, Shaozhuo
    Ren, Jie
    Liu, Bo
    Zhou, Taicheng
    Hu, Kunpeng
    LIVER RESEARCH, 2022, 6 (03) : 155 - 166
  • [40] HBx acts as an oncogene and promotes the invasion and metastasis of hepatocellular carcinoma both in vivo and vitro
    Yang, Shizhong
    Liu, Yanfeng
    Feng, Xiaobin
    Wang, Xiaojuan
    Wu, Meilong
    Gong, Lei
    Shu, Bin
    Lu, Qian
    Dong, Jiahong
    DIGESTIVE AND LIVER DISEASE, 2021, 53 (03) : 360 - 366